PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
15519221-1	2004	Previously, we have characterized the HIV-I(SF2) gp120 glycopeptides using matrix-assisted laser desorption/ionization mass spectrometry (MALDI/MS) and nanospray electrospray ionization (ESI).	Glycopeptides	55-68	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	49-54	
12565922-2	2003	Thus, the high-mannose type glycopeptides [gp120 (336-342)] containing Man(9), Man(6) and Man(5) moieties, respectively, were synthesized in satisfactory yields via transglycosylation to the acetylglucosaminyl peptide, using the recombinant Arthrobacter Endo-beta-N-acetyl-glucosaminidase (Endo-A) as the key enzyme.	Glycopeptides	28-41	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	43-48	
8419650-7	1993	Fragmentation of the gp120-derived 35SO4-labeled glycopeptides by treatment with hydrazine and nitrous acid and subsequent reduction generated galactosyl-anhydromannitol-6-35SO4, which is the expected reaction product from GlcNAc-6-sulfate within a sulfated lactosamine moiety.	Glycopeptides	49-62	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	21-26	
8419650-8	1993	Charge analysis of the [3H]galactose- and [3H]glucosamine-labeled glycopeptides from gp120 and gp160 indicates that approximately 14% of the complex-type N-linked oligosaccharides are sulfated.	Glycopeptides	66-79	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	85-90	
23831758-3	2013	We report here the design, synthesis and antigenic evaluation of new cyclic V1V2 glycopeptides carrying defined N-linked glycans at the conserved glycosylation sites (Asn160 and Asn156 or Asn173) derived from gp120 of two HIV-1 isolates.	Glycopeptides	81-94	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	209-214	
32439962-6	2020	Our identification of gp120 glycopeptide-induced, T cell-specific immune responses offers a foundation for developing future knowledge-based vaccines that elicit strong and long-lasting protective immune responses against HIV-1 infection.	Glycopeptides	28-40	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	22-27	
24884609-5	2014	First, we confirmed that the four ITIH4 N-X-S/T sequons (N81, N207, N517, and N577) were glycosylated by treating ITIH4 tryptic/GluC glycopeptides with PNGaseF in the presence of (18)O water.	Glycopeptides	133-146	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	34-39	
24884609-5	2014	First, we confirmed that the four ITIH4 N-X-S/T sequons (N81, N207, N517, and N577) were glycosylated by treating ITIH4 tryptic/GluC glycopeptides with PNGaseF in the presence of (18)O water.	Glycopeptides	133-146	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	114-119	
23909558-7	2013	By implementing the rules into an algorithm to score potential assignments against ETD-MS/MS data, we applied the method to glycopeptides generated from various O-glycosylated proteins including mucin, erythropoietin, fetuin, and an HIV envelope protein, 1086.C gp120.	Glycopeptides	124-137	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	262-267	
30115684-5	2018	Selective labeling of gp120 by N-azidoacetylmannosamine (ManNAz) and N-azidoacetylgalactosamine (GalNAz) incorporation into the gp120 glycan shield was characterized by MS of tryptic glycopeptides.	Glycopeptides	183-196	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	22-27	
30115684-5	2018	Selective labeling of gp120 by N-azidoacetylmannosamine (ManNAz) and N-azidoacetylgalactosamine (GalNAz) incorporation into the gp120 glycan shield was characterized by MS of tryptic glycopeptides.	Glycopeptides	183-196	inter-alpha-trypsin inhibitor heavy chain 4	Homo sapiens	128-133